ESAB Corp ESAB 深 沪
等待开盘 10-19 09:30:00 美东时间
65.35
-0.280
-0.43%
华盛通- 最 高66.22
- 今 开65.91
- 成交量 131.98万股
- 最 低 64.00
- 昨 收 65.63
- 总市值 406.27万
- 52周最高 137.08
- 市盈率 静 17.75
- 换手率 2123.02%
- 52周最低 62.74
- 委 比 0.00%
- 总股本 6.22万
- 历史最高 137.08
- 量 比 1.17
- 振 幅 3.38%
- 历史最低 30.82
- 每 手 1
- 风险率 17.76%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多ESAB收跌0.43%，成交额8602.95万美元
10月20-22日上海黄浦江畔，2026可持续全球领导者大会再度来袭。诺奖、图灵奖得主现场讲述科技未来与趋势，更有“解救”焦虑、内卷时代的网红教授——麦克法兰与...
10-17 05:11
ESAB Corporation (ESAB) Receives a Buy from Robert W. Baird
In a report released today, from Robert W. Baird maintained a Buy rating on ESA...
10-09 21:15
美股大行评级 | 潜在涨幅179.23%！奥本海默上调Aurora Innovation目标价至16美元，维持"跑赢大市"评级
今日重点评级关注：奥本海默：维持Aurora Innovation"跑赢大市"评级，目标价从15美元升至16美元；富国银行：维持Applied Digital"超配"评级，目标价从50美元升至55美元
10-09 16:25
JP Morgan Maintains Overweight on ESAB, Lowers Price Target to $95
JP Morgan analyst Tami Zakaria maintains ESAB (NYSE:ESAB) with a Overweight and lowers the price target from $125 to $95.
10-09 04:40
ESAB Q2 2026 Earnings Call: Complete Transcript
ESAB (NYSE:ESAB) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. Benzinga APIs provide real-time access to earnings call transcripts and financial data. Visit https://www.benzinga.com/apis/ to learn more. View the webcast at https://event...
10-05 19:21
美股大行评级 | 巴克莱大幅升Strategy目标价至160美元！康宁遭看淡至180美元，较现价仍溢价25%
今日重点评级关注：HC Wainwright & Co.：上调Cardiff Oncology评级至"买入"，目标价9美元；古根海姆：维持Inventiva"买入"评级，目标价从11美元升至14美元
09-16 16:10
Roth Capital Reiterates Buy on ESAB, Lowers Price Target to $133
Roth Capital analyst Thomas Hayes reiterates ESAB (NYSE:ESAB) with a Buy and lowers the price target from $151 to $133.
09-16 00:52
ESAB declares $0.12 dividend
ESAB (ESAB) declares $0.12/share quarterly dividend, in line with previous. Forward yield 0.69% Payable Oct. 16; for shareholders of record Oct. 2; ex-div Oct. 2. See ESAB Dividend Scorecard, Yield Ch...
09-11 12:24
美股大行评级 | 潜在涨幅207.38%！Truist Securities上调AbCellera Biologics目标价至30美元，维持"买入"评级
今日重点评级关注：Truist Securities：维持AbCellera Biologics"买入"评级，目标价从12美元升至30美元；Stifel：维持Proficient Auto Logistics"买入"评级，目标价从9美元升至12美元
08-12 08:45
Evercore ISI Group Maintains In-Line on ESAB, Lowers Price Target to $100
Evercore ISI Group analyst David Raso maintains ESAB (NYSE:ESAB) with a In-Line and lowers the price target from $103 to $100.
08-11 20:49
